What factors are associated with a woman's decision to take hormone replacement therapy? Evaluated in the context of a decision aid

Health Expectations

Volumn 6, Issue 2, 2003, Pages 110-117

  Clark, Heather D ^a,b   O'Connor, Annette M ^a,b   Graham, Ian D ^a,b,c   Wells, George A ^c  

^a UNIVERSITY OF OTTAWA   (Canada)

^b OTTAWA HOSPITAL RESEARCH INSTITUTE   (Canada)

^c UNIVERSITY OF OTTAWA   (Canada)

Author keywords

Decision support techniques; Decision making; Hormone replacement therapy; Menopause; Women education

Indexed keywords

HORMONE;

ADULT; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DECISION MAKING; FEMALE; HORMONE SUBSTITUTION; HUMAN; MAJOR CLINICAL STUDY; PATIENT COUNSELING; PHYSICIAN ATTITUDE; POSTMENOPAUSE; PRIORITY JOURNAL; QUALITATIVE ANALYSIS; QUALITY OF LIFE; RANDOMIZED CONTROLLED TRIAL; REVIEW;

CANADA; COUNSELING; DECISION MAKING; ESTROGEN REPLACEMENT THERAPY; FEMALE; HEALTH SERVICES RESEARCH; HUMANS; MIDDLE AGED; PATIENT ACCEPTANCE OF HEALTH CARE; PATIENT EDUCATION; PERSUASIVE COMMUNICATION; PHYSICIAN-PATIENT RELATIONS; UNCERTAINTY;

EID: 0038014075     PISSN: 13696513     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1369-6513.2003.00216.x     Document Type: Review

References (24)

1. Rabin DS, Cipparrone N, Linn ES, Moen M. Why menopausal women do not want to take hormone replacement therapy. Menopause, 1999; 6: 61-67.
2. The North American Menopause Society. A decision tree for the use of estrogen replacement therapy or hormone replacement therapy in postmenopausal women: consensus opinion of The North American Menopause Society. Menopause, 2000; 7: 76-86.
3. Anonymous. Guidelines for counseling postmenopausal women about preventive hormone therapy. American College of Physicians. Annals of Internal Medicine, 1992; 117: 1038-1041.
4. Society of Obstetricians and Gynecologists of Canada. Proceedings of the Canadian Menopause Conference. JSOGC, 1997; 16: 1-40.
5. Josse RG. Prevention and management of osteoporosis: consensus statements from the Scientific Advisory Board of the Osteoporosis Society of Canada. 3. Effects of ovarian hormone therapy on skeletal and extraskeletal tissues in women. Canadian Medical Association Journal, 1996; 155: 929-934.
6. O'Connor AM, Tugwell P, Wells GA et al. A decision aid for women considering hormone therapy after menopause: decision support framework and evaluation. Patient Education and Counseling, 1998; 33: 267-279.
7. O'Connor AM, Fiset V, DeGrasse C et al. Decision aids for patients considering options affecting cancer outcomes: evidence of efficacy and policy implications. Monographs of the National Cancer Institute, 1999; 25: 67-80.
8. O'Connor AM, Tugwell P, Wells GA et al. Randomized trial of a portable, self-administered decision aid for postmenopausal women considering longterm preventive hormone therapy. Medical Decision Making, 1998; 18: 295-303.
9. O'Connor AM, Tugwell P, Wells G. Testing a portable, self-administered decision aid for post-menopausal women considering long-term hormone replacement therapy to prevent osteoporosis and heart disease. Medical Decision Making, 1994; 14: 438.
10. Ware JE, Kosinski M, Keller SD. SF-12: How to Score the SF-12 Physical and Mental Summary Scales 2nd edn. 1995. Boston, MA: The Health Institute, New England Medical Center.
11. Hilditch JR, Lewis J, Peter A et al. A menopausespecific quality of life questionnaire: development and psychometric properties. Maturitas, 1996; 24: 161-175.
12. O'Connor AM. Validation of a decisional conflict scale. Medical Decision Making, 1995; 15: 25-30.
13. Holmes-Rovner M, Kroll J, Schmitt N et al. Patient satisfaction with health care decisions: the satisfaction with decision scale. Medical Decision Making, 1996; 16: 58-64.
14. Donner A, Klar N. Statistical considerations in the design and analysis of community intervention trials. Journal of Clinical Epidemiology, 1996; 49: 435-439.
15. Donner A, Klar N. Methods for comparing event rates in intervention studies when the unit of allocation is a cluster. American Journal of Epidemiology, 1994; 140: 279-289.
16. Zeger SL, Liang KY. Longitudinal data analysis for discrete and continuous outcomes. Biometrics, 1986; 42: 121-130.
17. Harrell FEJ, Lee KL, Mark DB. Multivariable prognostic models: issues in developing models, evaluating assumptions and adequacy, and measuring and reducing errors. Statistics in Medicine, 1996; 15: 361-387.
18. Gunst RF, Mason RL. Multicollinearity effects. In: Owen DB (ed.) Regression Analysis and its Application: a Data-Oriented Approach. New York, NY: Marcel Dekker Inc., 1980: 290-314.
19. Hosmer DW, Lemeshow S. Assessing Fit. Applied Logistic Regression. New York: John Wiley & Sons, 1989: 135-175.
20. Kadri AZ. Hormone replacement therapy - a survey of perimenopausal women in a community setting. British Journal of General Practice, 1991; 41: 109-112.
21. Ferguson KJ, Hoegh C, Johnson S. Estrogen replacement therapy. A survey of women's knowledge and attitudes. Archives of Internal Medicine, 1989; 149: 133-136.
22. Leveille SG, Lacroix AZ, Newton KM, Keenan NL. Older women and hormone replacement therapy: factors influencing late life initiation. Journal of the American Geriatrics Society, 1997; 45: 1496-1500.
23. Walsh JME, Brown JS, Rubin S, Kagawa M, Grady D. Postmenopausal hormone therapy: factors influencing women's decision making. Menopause, 1997; 4: 39-45.
24. Blumberg G, Kaplan B, Rabinerson D, Goldman GA, Kitai E, Neri A. Women's attitudes towards menopause and hormone replacement therapy. International Journal of Gynecology and Obstetrics, 1996; 54: 271-277.